Indian Researchers Discover Possible TB Drug Target
This article was originally published in PharmAsia News
Researchers in India believe they may have discovered a new way to target tuberculosis. The University of Hyderabad scientists say they identified a transport mechanism in bacteria that cause TB, one that allows them to siphon iron from the cells in which the bacteria dwell. The researchers say the work contributes to global understanding of the TB pathogen and its survival strategies. (Click here for more
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.